Sponsors (51)
The bill improves veterans' access to expensive medications and relieves facility-level drug costs, but shifts greater spending and administrative burden to the VA and taxpayers and risks supply delays or disputes.
Veterans in State nursing homes will have lower out-of-pocket costs and fewer barriers to obtaining high-cost medications because the VA will either reimburse the home or provide the drug directly.
Covered State homes and affiliated care providers will receive additional payments or direct supplies for expensive medicines, easing financial strain on those facilities and helping them continue providing care to veterans.
Taxpayers and the VA budget will likely face higher federal costs because the VA must pay for or supply medications whose monthly price exceeds the 8.5% threshold, increasing VA expenditures.
Veterans and State nursing homes could experience delays or interruptions in medication access if the VA's procurement or distribution is slower or less reliable than commercial suppliers.
State governments and care homes may have incentives to designate drugs as 'costly' to trigger VA payments, creating administrative complexity, disputes over pricing/eligibility, and extra bureaucratic burden.
Based on analysis of 2 sections of legislative text.
Allows VA to reimburse or directly furnish very high-cost medications to qualifying State veterans' homes, using a price-based threshold.
Introduced March 10, 2025 by Mariannette Miller-Meeks · Last progress March 10, 2025
Allows the Secretary of Veterans Affairs, when a State veterans’ home provides a high-cost medication to a veteran, to either reimburse that State home for the medication or to supply the medication directly. It defines a “costly medication” by a formula tied to the drug’s average wholesale price plus a 3% transaction fee compared to the VA’s monthly payment for that veteran’s care, and it defines which State homes are covered.